You can find the annual or quarterly income statement of ALX Oncology Holdings Inc here for insights into the performance and operational efficiency of ALX Oncology Holdings Inc.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

FY2019Q2

FY2019Q1

Total revenue

----

--0.00

-100.00%0.00

-59.31%527.00K

-36.53%655.00K

--1.21M

--1.26M

--1.29M

--1.03M

Revenue

----

--0.00

-100.00%0.00

-59.31%527.00K

-36.53%655.00K

--1.21M

--1.26M

--1.29M

--1.03M

Cost of revenue

----

--0.00

-100.00%0.00

----

-100.00%0.00

-59.30%479.00K

-36.46%596.00K

--1.10M

--1.14M

--1.18M

--938.00K

Operating expenses

-30.81%22.53M

-43.47%23.47M

-15.74%31.82M

-36.25%30.61M

-38.87%32.57M

12.91%41.52M

17.26%37.76M

49.05%48.02M

45.24%53.27M

8.84%36.78M

30.13%32.20M

13.16%32.22M

49.26%36.68M

107.31%33.79M

74.18%24.75M

59.73%28.47M

150.55%24.58M

44.06%16.30M

140.94%14.21M

99.25%17.82M

128.65%9.81M

106.31%11.31M

12.13%5.90M

--8.95M

--4.29M

--5.48M

--5.26M

R&D expenses

-34.11%17.44M

-47.99%18.02M

-24.68%23.89M

-43.68%23.53M

-42.16%26.47M

17.54%34.65M

28.08%31.72M

65.83%41.78M

55.76%45.77M

10.22%29.48M

45.04%24.76M

20.59%25.20M

61.32%29.38M

138.54%26.75M

73.35%17.07M

72.08%20.89M

241.85%18.21M

46.33%11.21M

157.29%9.85M

80.28%12.14M

141.09%5.33M

111.22%7.66M

2.54%3.83M

--6.74M

--2.21M

--3.63M

--3.73M

Depreciation, depletion, and amortization

-45.55%247.20K

16.12%461.00K

2.90%462.00K

41.72%462.00K

40.56%454.00K

24.45%397.00K

38.15%449.00K

50.93%326.00K

56.04%323.00K

62.76%319.00K

91.18%325.00K

47.95%216.00K

75.42%207.00K

106.32%196.00K

486.21%170.00K

2820.00%146.00K

2260.00%118.00K

-5.00%95.00K

-74.34%29.00K

-95.54%5.00K

-95.50%5.00K

-8.26%100.00K

13.00%113.00K

--112.00K

--111.00K

--109.00K

--100.00K

Operating profit

30.81%-22.53M

43.47%-23.47M

15.74%-31.82M

36.25%-30.61M

38.87%-32.57M

-12.91%-41.52M

-17.26%-37.76M

-49.05%-48.02M

-45.24%-53.27M

-8.84%-36.78M

-30.13%-32.20M

-13.16%-32.22M

-49.26%-36.68M

-107.31%-33.79M

-74.18%-24.75M

-59.73%-28.47M

-150.55%-24.58M

-51.10%-16.30M

-171.04%-14.21M

-130.51%-17.82M

-223.30%-9.81M

-157.51%-10.79M

-24.01%-5.24M

---7.73M

---3.03M

---4.19M

---4.23M

Net non-operating interest income (expenses)

Non-operating interest income

-65.18%802.00K

-56.85%1.11M

-43.44%1.48M

-37.30%1.88M

-13.97%2.30M

-3.86%2.56M

13.46%2.62M

65.74%3.00M

95.12%2.68M

203.64%2.67M

913.60%2.31M

--1.81M

--1.37M

--878.00K

--228.00K

----

Non-operating interest expense

-8.52%408.00K

-5.59%405.00K

-4.92%406.00K

2.89%427.00K

14.07%446.00K

15.32%429.00K

10.34%427.00K

20650.00%415.00K

19450.00%391.00K

18500.00%372.00K

12800.00%387.00K

-33.33%2.00K

-50.00%2.00K

-33.33%2.00K

0.00%3.00K

-98.01%3.00K

-98.23%4.00K

-98.63%3.00K

-98.60%3.00K

619.05%151.00K

--226.00K

--219.00K

--215.00K

--21.00K

--0.00

----

--0.00

Gains from sale of securities

----

--2.00K

----

Special income (expenses)

--0.00

---3.17M

----

--0.00

----

100.00%0.00

----

---621.00K

----

Other non-operating income (expenses)

-300.00%-6.00K

75.00%-2.00K

21.43%-11.00K

96.55%-1.00K

400.00%3.00K

-102.47%-8.00K

-114.74%-14.00K

87.55%-29.00K

88.89%-1.00K

4728.57%324.00K

963.64%95.00K

-1556.25%-233.00K

-164.29%-9.00K

-125.00%-7.00K

-142.31%-11.00K

220.00%16.00K

112.61%14.00K

109.18%28.00K

271.43%26.00K

600.00%5.00K

-5450.00%-111.00K

---305.00K

450.00%7.00K

---1.00K

---2.00K

--0.00

---2.00K

Income before tax

27.89%-22.14M

34.14%-25.95M

13.57%-30.75M

35.87%-29.16M

39.78%-30.71M

-15.34%-39.40M

-17.88%-35.58M

-48.38%-45.47M

-44.37%-50.99M

-3.76%-34.16M

-23.03%-30.18M

-7.68%-30.64M

-43.78%-35.32M

-102.29%-32.92M

-72.95%-24.53M

-53.07%-28.46M

-142.12%-24.57M

-43.88%-16.27M

-160.28%-14.19M

-139.74%-18.59M

-234.19%-10.15M

-170.02%-11.31M

-28.87%-5.45M

---7.75M

---3.04M

---4.19M

---4.23M

Income tax

----

-100.00%0.00

----

404.76%64.00K

----

-111.54%-21.00K

-100.00%0.00

1922.22%182.00K

337.50%35.00K

150.00%20.00K

-55.56%4.00K

--9.00K

--8.00K

--9.00K

Income after tax

27.89%-22.14M

34.14%-25.95M

13.57%-30.75M

35.87%-29.16M

39.78%-30.71M

-15.34%-39.40M

-17.88%-35.58M

-48.07%-45.47M

-44.37%-50.99M

-3.76%-34.16M

-23.03%-30.18M

-7.99%-30.71M

-43.78%-35.32M

-102.29%-32.92M

-72.95%-24.53M

-51.48%-28.44M

-141.29%-24.57M

-43.62%-16.27M

-160.08%-14.19M

-141.81%-18.77M

-234.46%-10.18M

-169.98%-11.33M

-28.69%-5.45M

---7.76M

---3.04M

---4.20M

---4.24M

Net income from continuous operations

27.89%-22.14M

34.14%-25.95M

13.57%-30.75M

35.87%-29.16M

39.78%-30.71M

-15.34%-39.40M

-17.88%-35.58M

-48.07%-45.47M

-44.37%-50.99M

-3.76%-34.16M

-23.03%-30.18M

-7.99%-30.71M

-43.78%-35.32M

-102.29%-32.92M

-72.95%-24.53M

-51.48%-28.44M

-141.29%-24.57M

-43.62%-16.27M

-160.08%-14.19M

-141.81%-18.77M

-234.46%-10.18M

-169.98%-11.33M

-28.69%-5.45M

---7.76M

---3.04M

---4.20M

---4.24M

Net income attributable to controlling interests

27.89%-22.14M

34.14%-25.95M

13.57%-30.75M

35.87%-29.16M

39.78%-30.71M

-15.34%-39.40M

-17.88%-35.58M

-48.07%-45.47M

-44.37%-50.99M

-3.76%-34.16M

-23.03%-30.18M

-7.99%-30.71M

-43.78%-35.32M

-102.29%-32.92M

-72.95%-24.53M

-51.48%-28.44M

-128.33%-24.57M

-16.48%-16.27M

-90.74%-14.19M

-112.50%-18.77M

-161.46%-10.76M

-169.83%-13.97M

-44.60%-7.44M

---8.84M

---4.12M

---5.18M

---5.14M

Preferred share dividend

----

--0.00

-100.00%0.00

-46.03%578.00K

169.22%2.64M

119.12%1.98M

--1.07M

--981.00K

--905.00K

Net income attributable to common shareholders

27.89%-22.14M

34.14%-25.95M

13.57%-30.75M

35.87%-29.16M

39.78%-30.71M

-15.34%-39.40M

-17.88%-35.58M

-48.07%-45.47M

-44.37%-50.99M

-3.76%-34.16M

-23.03%-30.18M

-7.99%-30.71M

-43.78%-35.32M

-102.29%-32.92M

-72.95%-24.53M

-51.48%-28.44M

-128.33%-24.57M

-16.48%-16.27M

-90.74%-14.19M

-112.50%-18.77M

-161.46%-10.76M

-169.83%-13.97M

-44.60%-7.44M

---8.84M

---4.12M

---5.18M

---5.14M

Basic earnings per share

29.07%-0.41

36.13%-0.49

18.81%-0.58

41.80%-0.54

52.97%-0.58

9.04%-0.76

3.89%-0.71

-22.98%-0.93

-42.96%-1.24

-3.29%-0.84

-22.29%-0.74

-7.41%-0.75

-42.54%-0.87

-100.10%-0.81

-70.56%-0.60

30.91%-0.70

-109.74%-0.61

-6.98%-0.40

-65.29%-0.35

-299.02%-1.02

-144.57%-0.29

-153.38%-0.38

-44.61%-0.21

---0.25

---0.12

---0.15

Diluted earnings per share

29.07%-0.41

36.13%-0.49

18.81%-0.58

41.80%-0.54

52.97%-0.58

9.04%-0.76

3.89%-0.71

-22.98%-0.93

-42.96%-1.24

-3.29%-0.84

-22.29%-0.74

-7.41%-0.75

-42.54%-0.87

-100.10%-0.81

-70.56%-0.60

30.91%-0.70

-109.74%-0.61

-6.98%-0.40

-65.29%-0.35

-299.02%-1.02

-144.57%-0.29

-153.38%-0.38

-44.61%-0.21

---0.25

---0.12

---0.15

Dividend per share

--0.00

Currency unit

USD

Audit opinions

FAQs

What is the income statement?



The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.

KeyAI

